Diabetes drug could boost standard arthritis treatment
NCT ID NCT04196868
Summary
This study is testing if adding the common diabetes medication metformin to the standard first-line arthritis drug methotrexate works better for controlling rheumatoid arthritis. It will involve 128 adults with active rheumatoid arthritis who are starting methotrexate treatment. The main goal is to see if the drug combination leads to lower disease activity after six months compared to methotrexate alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH de Cahors - service de rhumatologie
Cahors, France
-
CH de Libourne - service de rhumatologie
Libourne, France
-
CH de Pau - service de rhumatologie
Pau, France
-
CH de la Côte Basque - service de rhumatologie
Bayonne, France
-
CH du Mans - service de rhumatologie
Le Mans, France
-
CHD de Vendée - service de rhumatologie
La Roche-sur-Yon, France
-
CHR Orléans la Source - service de rhumatologie
Orléans, France
-
CHU de Bordeaux - service de rhumatologie
Bordeaux, France
-
CHU de Brest - service de rhumatologie
Brest, France
-
CHU de Montpellier - service de rhumatologie
Montpellier, France
-
CHU de Toulouse - service de rhumatolgie
Toulouse, France
-
Clinique de l'Infirmerie protestante de Lyon - service de rhumatologie
Caluire-et-Cuire, France
Conditions
Explore the condition pages connected to this study.